https://www.selleckchem.com/products/jzl184.html
This article is categorized under Therapeutic Approaches and Drug Discovery Nanomedicine for Oncologic Disease.Most studies choose passivators essentially in a trial-and-error fashion in an attempt to attain high efficiency in perovskite solar cells (PSCs). Using deep-level transient spectroscopy (DLTS) measurements, the type of defects in perovskite films was determined to guide the passivator selection for PSCs. Three kinds of positively charged defects were found in the target PSC system. Fluorinated phenylethylamine hydroiodide
Like
Comment
Share
